FGF2 and cancer: In transformed tumor cell lines and in malignant tumors, overexpressed PTTG triggers production of FGF-2 and VEGF-A, cell cycle progression and angiogenesis, and in malignant tumors, high PTTG levels correlate with tumor invasiveness and serve as a marker of poor prognosis (reviewed in [26]).